Trade Vir Biotechnology ^VIR

Vir Biotechnology (NASDAQ:VIR) Shares Gap Down - What's Next?

Gilead Cancer Deal Could Be A Game Changer For Vir Biotechnology (VIR)

Vir Biotechnology (NASDAQ:VIR) Shares Gap Down - Here's What Happened - Stock Observer

Vir Biotechnology (VIR) Projected to Post Quarterly Earnings on Wednesday

Vir Biotechnology (NASDAQ:VIR) Shares Cross Above 50-Day Moving Average - What's Next?

Is Vir Biotechnology (VIR) Undervalued On Its Gilead Oncology Deal?

Comparing Vir Biotechnology (NASDAQ:VIR) and REGENXBIO (NASDAQ:RGNX) - Markets Daily

Vir Biotechnology, Inc. (VIR) - What Are Investment Firms Thinking About This Stock?

Hepatitis B Virus (HBV) Infection Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Ascletis Pharma, Shanghai HEP Pharma, Romark Lab, GSK | ABNewswire

Vir Biotechnology (NASDAQ:VIR) & REGENXBIO (NASDAQ:RGNX) Head-To-Head Survey - Stock Observer

Did Cancer Drug Partnership Just Shift Gilead's (GILD) Investment Narrative? - Simply Wall St News

Could Vir Biotechnology (VIR) Be Above Fair Value After Recent Pipeline News?

I'm Taking Out Some 'Insurance' on My Portfolio With These 2 Stocks

What Could Gilead Sciences (GILD) New Solid Tumor Partnership Mean For Oncology?

Gilead Sciences, Inc. $GILD Stake Trimmed by Curated Wealth Partners LLC - Zolmax

Vir Biotechnology and Gilead Sciences Forge $1.88 Billion Collaboration for Solid Tumor Cancer Therapies, ETPharma

Vir partners with Gilead in $1.8B+ deal for T-cell engagers

Verastem focuses on KRAS G12D therapy, reports 41% ORR in PDAC

Vir Biotechnology Partners With Gilead On Next-Generation Cancer Immunotherapy Programs

Vir Biotechnology Shares Jump on Gilead Cancer Collaboration | Morningstar

Vir CEO sees 'opportunity to do more deals' after striking $1.9B Gilead pact for dual-masked TCEs

Vir Biotechnology (NASDAQ:VIR) Shares Gap Up - What's Next? - Daily Political

Is FDA Fast Track Status Altering The Investment Case For Vir Biotechnology (VIR)?

Is Vir Biotechnology (VIR) Cheap On Fast Track News And SOLSTICE Data Hopes?

Vir Biotechnology (NASDAQ:VIR) Hits New 52-Week High - Here's What Happened

Vir Biotechnology (NASDAQ:VIR) Shares Down 6.5% - Time to Sell? - Stock Observer

Vir Biotechnology (NASDAQ:VIR) Shares Climb 6.1% - Here's Why - Stock Observer

Vir Biotechnology (NASDAQ:VIR) Shares Down 6.5% - Here's What Happened

Vir Biotechnology (NASDAQ:VIR) Stock Bumped Down to "Strong Sell" by Zacks Research - Markets Daily

Vir Biotechnology (NASDAQ:VIR) Cut to "Strong Sell" at Zacks Research

How Upcoming SOLSTICE Phase 2 HDV Data Could Shape Vir Biotechnology's (VIR) Investment Narrative

VIR Maintains by HC Wainwright & Co. -- Price Target Raised to $

Vir Biotechnology (NASDAQ:VIR) Given New $22.00 Price Target at HC Wainwright

Vir Biotechnology to Present Expanded Phase 2 SOLSTICE Results for Elebsiran and Tobevibart in Hepatitis Delta at AASLD's The Liver Meeting® 2026 | Morningstar

Vir Biotechnology (VIR) Could Be 48% Undervalued Following Its CFO Appointment

Vir Biotechnology, Inc. (NASDAQ:VIR) Stock Rated "Moderate Buy" by Sell-Side Brokerages

Boeing Stock Forecast 2026–2030: Can a Record $745 Billion Backlog Reverse BA’s 11% Earnings Sell-Off?

CoreWeave Stock Forecast 2026–2030: Can CRWV Recover From the AI Debt Sell-Off?

Pound to Rand Forecast: Can GBP/ZAR Break Above 22?

Nebius Stock Price Prediction 2026–2030: Can AI Cloud Growth Justify the Cost?

Eli Lilly Stock Forecast 2026–2030: Can LLY Break Above $1,300 After Its 7% Five-Session Rally?

Is Oracle a Good Buy Right Now? Growth, Valuation and Long-Term Risks

Best Stock CFD Broker in 2026: 9 Platforms Compared

Is SpaceX a Good Stock to Buy in 2026?

Best Gold Stock to Buy Now: 6 Gold Stocks to Watch in 2026

Advanced CFD Trading Tools Review: Which Tools Can Improve Your Trading Decisions?

Gold Price Today: XAU/USD Holds Near $4,050 as Fed Pause Leaves Rate Risks in Focus

Alphabet Stock Falls About 10% After Earnings Miss as AI Spending Weighs on Cash Flow

Microsoft Stock Rises as Azure Growth Hits 48% and Revenue Beats Forecasts

Samsung Q3 Profit Surges Nearly Ninefold as AI Memory Shortage Set to Deepen in 2027

US GDP and PCE Inflation Today: Will Hot Data Lock In a December Fed Rate Hike?

Fed Holds Rates at 4% as December Hike Odds Jump to 85% and 10-Year Yield Tops 5%

Bitcoin Reclaims $81,000 After Fed Holds Rates, but Inflation Risks Remain

Broadcom Stock Rises 4% as $63 Billion Anthropic Financing Supports AI Outlook